Cargando…

Renal cell carcinoma induces interleukin 10 and prostaglandin E(2) production by monocytes

Immunotherapy with interleukin 2 (IL-2) is not an effective anti-cancer treatment in the majority of patients with renal cell carcinoma (RCC), suggesting that the activation of cytotoxic T cells or NK cells may be impaired in vivo in these patients. The production of immunosuppressive factors by RCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ménétrier-Caux, C, Bain, C, Favrot, M C, Duc, A, Blay, J Y
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362183/ https://www.ncbi.nlm.nih.gov/pubmed/10408703 http://dx.doi.org/10.1038/sj.bjc.6690021

Ejemplares similares

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma.
por: Bain, C., et al.
Publicado: (1997)

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
por: Bachelot, T, et al.
Publicado: (2003)

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
por: Ménétrier-Caux, Christine, et al.
Publicado: (2019)

Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
por: Wittke, F, et al.
Publicado: (1999)

Prostaglandin E inhibits the production of human interleukin 2
Publicado: (1982)

Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3(+) regulatory T cells and are associated with poor prognosis in breast cancer patients
por: Sisirak, Vanja, et al.
Publicado: (2013)

Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment
por: Ménétrier-Caux, Christine, et al.
Publicado: (2012)

Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages
Publicado: (1978)

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006)

Pretreatment serum CRP and response to interleukin 2.
por: Blay, J. Y., et al.
Publicado: (1994)

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4(+) T cells by plasmacytoid dendritic cells
por: Faget, Julien, et al.
Publicado: (2013)

Immunohistochemical Demonstration of Membrane-bound Prostaglandin E(2) Synthase-1 in Papillary Thyroid Carcinoma
por: Omi, Yoko, et al.
Publicado: (2009)

Interferon gamma inhibits interleukin 10 production by monocytes
Publicado: (1993)

Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production
Publicado: (1995)

Is prostaglandin E2 involved in the pathogenesis of fever? Effects of interleukin-1 on the release of prostaglandins.
por: Bernheim, H. A.
Publicado: (1986)

Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2
Publicado: (1994)

Effect of Intestinal Microflora on the Production of Interleukin 10 and Prostaglandin E(2) in Serum and Kupffer Cells from Germfree and Conventional Mice
por: Ikeda, Masamichi, et al.
Publicado: (2007)

Monocytes regulate osteoclast-activating factor production by releasing prostaglandins
Publicado: (1979)

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
Publicado: (1996)

Novel Roles for Hypoxia and Prostaglandin E(2) in the Regulation of IL-8 During Endometrial Repair
por: Maybin, Jacqueline A., et al.
Publicado: (2011)

MDR1 in immunity: friend or foe?
por: Bossennec, Marion, et al.
Publicado: (2018)

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E(2) results in high interleukin-12 production and cell migration
por: Boullart, A. C. Inge, et al.
Publicado: (2008)

Green, Black and Rooibos Tea Inhibit Prostaglandin E2 Formation in Human Monocytes by Inhibiting Expression of Enzymes in the Prostaglandin E2 Pathway
por: Hedbrant, Alexander, et al.
Publicado: (2022)

Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study
por: Herpen, C M L van, et al.
Publicado: (2000)

Interleukin-10 and prostaglandin E(2) have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma
por: Brencicova, Eva, et al.
Publicado: (2017)

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma
por: Boyano, M D, et al.
Publicado: (2000)

Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma.
por: Négrier, S., et al.
Publicado: (1992)

Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate
por: Wang, L-S, et al.
Publicado: (1999)

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes
Publicado: (1991)

Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway
por: Maini, Alexander A., et al.
Publicado: (2021)

Prostaglandin E(2) Does Not Modulate CCR7 Expression and Functionality after Differentiation of Blood Monocytes into Macrophages
por: Allaire, Marc-André, et al.
Publicado: (2013)

N-Acetylcysteine enhances the action of anti-inflammatory drugs as suppressors of prostaglandin production in monocytes.
por: Hoffer, Erica, et al.
Publicado: (2002)

Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture.
por: Atkins, D., et al.
Publicado: (1977)

PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11β-hydroxysteroid dehydrogenase activity by prostaglandin E(2) in human granulosa–lutein cells
por: Chandras, C, et al.
Publicado: (2007)

Prostaglandin E (2) and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells
por: Chen, Y, et al.
Publicado: (2000)

Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts
por: Matsumoto-Taniura, N, et al.
Publicado: (1999)

Expression of prostaglandin E(2) prostanoid receptor EP2 and interleukin-1β in laryngeal carcinoma – preliminary study
por: Mochocki, Marcin, et al.
Publicado: (2015)

Regulation of intraluteal production of prostaglandins
por: Wiltbank, Milo C, et al.
Publicado: (2003)

Prostaglandin E2 Antagonizes TGF-β Actions During the Differentiation of Monocytes Into Dendritic Cells
por: Remes Lenicov, Federico, et al.
Publicado: (2018)

Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
por: Mutsaers, Henricus A.M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tsvaqqg9oiu70e3ahfuus2am61